Integra LifeSciences IART Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's change in other liabilities?
- Integra LifeSciences (IART) reported change in other liabilities of $369K in Q1 2026.
- How has Integra LifeSciences's change in other liabilities changed year-over-year?
- Integra LifeSciences's change in other liabilities decreased by 73.4% year-over-year, from $1.39M to $369K.
- What is the long-term trend for Integra LifeSciences's change in other liabilities?
- Over 2 years (2021 to 2025), Integra LifeSciences's change in other liabilities has grown at a 10.3% compound annual growth rate (CAGR), from -$14.11M to -$17.16M.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.